SEK283.40
0.43% today
Stockholm, Aug 18, 05:29 pm CET
ISIN
SE0009858152
Symbol
BONEX

Bonesupport Holding AB Stock price

SEK283.40
-41.00 12.64% 1M
-63.20 18.23% 6M
-103.40 26.73% YTD
+4.60 1.65% 1Y
+208.95 280.66% 3Y
+237.70 520.13% 5Y
+251.40 785.63% 10Y
+251.40 785.63% 20Y
Stockholm, Closing price Mon, Aug 18 2025
+1.20 0.43%
ISIN
SE0009858152
Symbol
BONEX
Industry

Key metrics

Basic
Market capitalization
SEK18.7b
Enterprise Value
SEK18.4b
Net debt
positive
Cash
SEK309.7m
Shares outstanding
66.8m
Valuation (TTM | estimate)
P/E
126.5 | 65.9
P/S
17.6 | 14.4
EV/Sales
17.4 | 14.2
EV/FCF
89.0
P/B
23.5
Financial Health
Equity Ratio
82.7%
Return on Equity
18.4%
ROCE
23.6%
ROIC
31.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
SEK1.1b | SEK1.3b
EBITDA
SEK196.5m | SEK297.6m
EBIT
SEK189.7m | SEK291.1m
Net Income
SEK148.0m | SEK286.1m
Free Cash Flow
SEK207.2m
Growth (TTM | estimate)
Revenue
44.5% | 44.9%
EBITDA
149.6% | 271.4%
EBIT
178.2% | 299.3%
Net Income
-48.8% | 113.9%
Free Cash Flow
816.2%
Margin (TTM | estimate)
Gross
92.6%
EBITDA
18.5% | 22.9%
EBIT
17.9%
Net
13.9% | 22.0%
Free Cash Flow
19.5%
More
EPS
SEK2.2
FCF per Share
SEK3.1
Short interest
-
Employees
140
Rev per Employee
SEK6.4m
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Bonesupport Holding AB forecast:

11x Buy
85%
1x Hold
8%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Bonesupport Holding AB forecast:

Buy
85%
Hold
8%
Sell
8%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,062 1,062
45% 45%
100%
- Direct Costs 79 79
38% 38%
7%
984 984
45% 45%
93%
- Selling and Administrative Expenses 677 677
26% 26%
64%
- Research and Development Expense 89 89
38% 38%
8%
197 197
150% 150%
18%
- Depreciation and Amortization 6.82 6.82
35% 35%
1%
EBIT (Operating Income) EBIT 190 190
178% 178%
18%
Net Profit 148 148
49% 49%
14%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Mr. Billback
Employees 140
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today